The classification of mood disorders lacks precision and consequently there
has been no recent meaningful advance in their treatment. By virtue of its
therapeutic specificity, lithium responsivity offers an opportunity to
diagnose a definitive subtype of mood disorders that may provide a platform
for the development of targeted therapy.